Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
Date:4/21/2008

IRVINE, Calif., April 21 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release first quarter 2008 financial results on April 30, 2008, after the U.S. markets close. ISTA will host a conference call, with a simultaneous webcast, to discuss these results at 4:30 p.m. Eastern Time on April 30.

To access the live conference call, U.S. and Canadian participants may dial 866-362-5158; international participants may dial 617-597-5397. The access code for the live call is 62850877. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 41268029. This conference call also will be webcast live and archived on ISTA's website until May 30, 2008, at http://www.istavision.com.

About ISTA

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
2. Amylin Pharmaceuticals Reports First Quarter Financial Results
3. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
4. Access Pharmaceuticals Announces New Data on Angiolix(R)
5. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
6. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
7. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
8. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
9. Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
10. ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM)
11. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... LEBANON, Tenn., Nov. 9 Health Con...nounced it will host their inaugural Hospital O.R....010 at the Marriott Renaissance Hotel in Nashville... more than 100 hospital operating room directors a... health systems in the country. Some of the confir...
(Date:11/9/2009)... DETROIT, Nov. 9 For th... Cancer Center has been selected the most preferre...according to a survey by the National Research Cor...gi-bin/prnh/20071106/KARMANOSLOGO ) ,, The ann...naire between September 2008 and August 2009. Surv...
(Date:11/9/2009)... didn,t answer question of why this is so, however...- After a lumpectomy, women with very dense breast...ffected breast, a new study shows. , Breast den...k of developing breast cancer, and experts have su...ated with an increased risk of cancer recurrence a...
(Date:11/9/2009)... ROCHESTER, Minn., Nov. 9 /PRNewswire-USNewswire/ ... surgery for vaginal prolapse dramatically red...e findings are being presented this week at the No...ociation in Scottsdale, Ariz. ,, (Logo: http... ) ,, VIDEO ALERT : Additional audio and vide...
(Date:11/9/2009)... - Parents Support Experimental Procedure for Pr...re-USNewswire/ -- For parents of children with can...ates have steadily improved for decades. Among the... cause infertility. ,, Boys diagnosed with ca...portunity to preserve their fertility: before unde...
Breaking Medicine News(10 mins):Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4
...lood volume explains it , , TUESDAY, Nov. ...ve learned that they need to adjust the results of...in obese men, but now researchers think they know ...new study doesn,t definitively prove why overweigh...
...ressure, more weight loss, study finds , ,...tart a walking program for their health get more o...s their steps, a new study shows. , "People who us...ntist at Stanford University. "They also seem to l...
...nth, ARLINGTON, Va., Nov. 20 Thanks to homecare,...t the U.S. will celebrate,Thanksgiving and other h...r,homes. During November, which is National Homeca...ically sound,cost-effective care in a patient-pref...
...each children how to keep hands clean, MORRIS PLA...uts a hand in his/her nose or mouth. Considering t...r longer on surfaces like,cafeteria tables, doorkn... for Disease Control and Prevention (CDC),keeping ...
...R, Nov. 20 /PRNewswire-FirstCall/ - Cardiome Pharm...itiation of subject dosing in its,Phase 1 study of...ose-ranging study will measure the safety, tolerab... 24-hour continuous,intravenous infusion of GED-aP...
...on Optics,Corporation, Inc. (OTC Bulletin Board: P...sults on an unaudited basis for the first quarter ...st Quarter Operating Results Revenues -- Total re...ts the second highest quarterly revenue in six,yea...
Other Medicine News:Health News:Why Obese Men Post Lower PSA Levels 2Health News:Pedometer Pushes People to Walk More 2Health News:Thanks to Homecare, Millions of Older Americans Celebrate Thanksgiving and Other Holidays at Home 2Health News:Proper Hand Hygiene Is Key to Avoiding Illness During Cold and Flu Season 2Health News:Cardiome Initiates Phase 1 Study for GED-aPC 2Health News:Cardiome Initiates Phase 1 Study for GED-aPC 3Health News:Cardiome Initiates Phase 1 Study for GED-aPC 4Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 2Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 3Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 4Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 5Health News:Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order 6
(Date:11/9/2009)...wire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT )...athologists, oncologists and the pharmaceutical in...ke presentations at two upcoming investor conferen... will be made at the Lazard Capital Markets Sixth ...sday, November 17. The conference will be held at ...
(Date:11/7/2009)...re/ -- Patients reported C1-esterase inhibitor (C1...ing acute swelling attacks at any body location fo...ing to data presented today at the 2009 American C... Annual Meeting. The results come from a self-repo... the ongoing, prospective, open label I nternatio...
(Date:11/6/2009)...rstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bull...y approved reverse split of its common stock will .... 9, 2009 on a 1-for-15 split-adjusted basis. Oxyg...he new symbol OXBT. The stock also will have a new... effective. ,, "This reverse split was overwhel...
Breaking Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Prospect Therapeutics In Vitro Studies Demonstrate that GCS 100 Drug Binds to and Blocks the Effects of Galectin 3 48875 1Prospect Therapeutics In Vitro Studies Demonstrate that GCS 100 Drug Binds to and Blocks the Effects of Galectin 3 48875 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 1Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 3Quest Diagnostics to Speak at the Jefferies 3rd Annual Healthcare Conference 48867 1
Premier Encore Mini C-Arm
KM-500 Hand-Held Auto Keratometer
Herrick Lacrimal Plugs
Khosla Cryo Ultra
Medicine Products: